MELINTA THERAPEUTICS, INC. /NEW/
Industry: Pharmaceuticals (See others in industry)
Address:
300 George Street Suite 301
New Haven, CT, 06511
Phone: 312 767 0291
New Haven, CT, 06511
Phone: 312 767 0291
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2018-01-19 | New | $137,781,477 | $137,781,477 | Equity Only | 06b | SEC link |
| 2017-11-20 | New | $132,914,810 | $132,914,810 | Equity Only | 06b | SEC link |
| 2012-10-30 | New | $25,119,996 | $25,119,996 | Equity Only | 06 | SEC link |
| 2011-08-16 | New | $5,000,000 | $5,000,000 | Debt Only | 06 | SEC link |
| 2010-05-19 | Amended | $45,999,999 | $20,500,000 | Equity Only | 06 | SEC link |
| 2009-05-20 | New | $25,499,999 | $25,499,999 | Equity Only | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Shane Barton | Executive |
| Sue Cammarata | Executive |
| Michael L. Corrado | Director |
| Erin Duffy | Executive |
| Paul Estrem | Executive |
| Prabhavathi Fernandes | Director, Executive |
| Kevin T. Ferro | Director |
| Robin Gadsby | Director |
| Jay Galeota | Director |
| Jay J. Galeota, Jr. | Director |
| David Gill | Director |
| Dov Goldstein | Director |
| Cecilia Gonzalo | Director |
| Mark Hahn | Executive |
| John H. Johnson | Director |
| Richard Kent | Director |
| Thomas P. Koestler | Director |
| Garheng Kong | Director |
| I Wistar Morris | Director |
| P. Sherill Neff | Director |
| John Niedermayer | Executive |
| John Temperato | Executive |
| Geeta Vemuri | Director |
| Daniel Wechsler | Director, Executive |
| David Zaccardelli | Director |